The third lung cancer-derived exosomal lncRNA is MSTRG.292666.16, which contributes to the acquired osimertinib resistance of lung cancer cells through regulating expression levels of miR-21, miR-125b, TGFβ, and ARF6 (148). Here, ARF6 is linked to lung cancer.